<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(9)</volume><submitter>van der Linden M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Vulvar Paget disease is a rare skin disorder, which is most common in postmenopausal Caucasian women. They usually present with an erythematous plaque that may show fine or typical "cake icing" scaling or ulceration that may cause itching, pain, irritation, or a burning sensation. Although most cases are noninvasive, vulvar Paget disease may be invasive or associated with an underlying vulvar or distant adenocarcinoma. The histological evidence of so-called "Paget cells" with abundant pale cytoplasm in the epithelium confirms the diagnosis. The origin of these Paget cells is still unclear. Treatment of choice is wide local excision with negative margins. Obtaining clear surgical margins is challenging and may lead to extensive and mutilating surgery. Even then, recurrenc</pubmed_abstract><journal>JMIR research protocols</journal><pagination>e178</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5607434</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease.</pubmed_title><pmcid>PMC5607434</pmcid><pubmed_authors>Meeuwis K</pubmed_authors><pubmed_authors>Bosse T</pubmed_authors><pubmed_authors>van Hees C</pubmed_authors><pubmed_authors>van Beurden M</pubmed_authors><pubmed_authors>van Dorst E</pubmed_authors><pubmed_authors>Bulten J</pubmed_authors><pubmed_authors>van der Linden M</pubmed_authors><pubmed_authors>van Poelgeest M</pubmed_authors><pubmed_authors>de Hullu J</pubmed_authors><pubmed_authors>Slangen B</pubmed_authors><pubmed_authors>IntHout J</pubmed_authors><pubmed_authors>van Seters M</pubmed_authors><pubmed_authors>Boll D</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease.</name><description>&lt;h4>Background&lt;/h4>Vulvar Paget disease is a rare skin disorder, which is most common in postmenopausal Caucasian women. They usually present with an erythematous plaque that may show fine or typical "cake icing" scaling or ulceration that may cause itching, pain, irritation, or a burning sensation. Although most cases are noninvasive, vulvar Paget disease may be invasive or associated with an underlying vulvar or distant adenocarcinoma. The histological evidence of so-called "Paget cells" with abundant pale cytoplasm in the epithelium confirms the diagnosis. The origin of these Paget cells is still unclear. Treatment of choice is wide local excision with negative margins. Obtaining clear surgical margins is challenging and may lead to extensive and mutilating surgery. Even then, recurrenc</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Sep</publication><modification>2025-04-05T12:07:33.616Z</modification><creation>2019-03-27T02:56:58Z</creation></dates><accession>S-EPMC5607434</accession><cross_references><pubmed>28877863</pubmed><doi>10.2196/resprot.7503</doi></cross_references></HashMap>